tradingkey.logo

Niagen Bioscience Inc

NAGE
6.510USD
-0.200-2.98%
收盘 12/23, 16:00美东报价延迟15分钟
518.45M总市值
24.82市盈率 TTM

Niagen Bioscience Inc

6.510
-0.200-2.98%

关于 Niagen Bioscience Inc 公司

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Niagen Bioscience Inc简介

公司代码NAGE
公司名称Niagen Bioscience Inc
上市日期Jun 25, 2007
CEOFried (Robert N)
员工数量104
证券类型Ordinary Share
年结日Jun 25
公司地址10900 Wilshire Blvd Suite 600
城市LOS ANGELES
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编90024
电话13103886706
网址https://www.niagenbioscience.com/
公司代码NAGE
上市日期Jun 25, 2007
CEOFried (Robert N)

Niagen Bioscience Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
1.65M
+4.22%
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
7.37K
+153.59%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Ben Shamsian
Mr. Ben Shamsian
Investor Relations
Investor Relations
--
--
Ms. Ann Cohen
Ms. Ann Cohen
Independent Director
Independent Director
--
--
Mr. Gary Ng
Mr. Gary Ng
Independent Director
Independent Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--
Ms. Kristin Patrick
Ms. Kristin Patrick
Independent Director
Independent Director
--
--
Mr. Hamed Shahbazi
Mr. Hamed Shahbazi
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
1.65M
+4.22%
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
7.37K
+153.59%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Ben Shamsian
Mr. Ben Shamsian
Investor Relations
Investor Relations
--
--
Ms. Ann Cohen
Ms. Ann Cohen
Independent Director
Independent Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Brilliant Dynasty Ltd
14.30%
Pioneer Step Holdings, Ltd.
8.67%
The Vanguard Group, Inc.
5.02%
Nestle Health Science US Holdings, Inc.
4.78%
BlackRock Institutional Trust Company, N.A.
4.37%
其他
62.86%
持股股东
持股股东
占比
Brilliant Dynasty Ltd
14.30%
Pioneer Step Holdings, Ltd.
8.67%
The Vanguard Group, Inc.
5.02%
Nestle Health Science US Holdings, Inc.
4.78%
BlackRock Institutional Trust Company, N.A.
4.37%
其他
62.86%
股东类型
持股股东
占比
Corporation
31.56%
Investment Advisor
19.17%
Investment Advisor/Hedge Fund
13.94%
Hedge Fund
5.70%
Individual Investor
2.44%
Research Firm
1.42%
Pension Fund
0.68%
Bank and Trust
0.23%
Venture Capital
0.07%
其他
24.79%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
277
29.97M
37.55%
+806.79K
2025Q2
256
54.09M
67.83%
+1.52M
2025Q1
248
52.79M
67.45%
+991.43K
2024Q4
227
50.32M
64.79%
+3.69M
2024Q3
187
45.29M
58.88%
-2.22M
2024Q2
176
44.12M
58.29%
+362.19K
2024Q1
173
40.79M
55.40%
+2.41M
2023Q4
177
39.03M
53.11%
+1.29M
2023Q3
191
38.74M
52.74%
+56.61K
2023Q2
203
38.69M
53.76%
+732.31K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Brilliant Dynasty Ltd
11.41M
14.31%
+11.41M
--
Aug 20, 2024
Pioneer Step Holdings, Ltd.
6.92M
8.67%
--
--
Aug 20, 2024
The Vanguard Group, Inc.
3.92M
4.92%
+383.90K
+10.84%
Jun 30, 2025
Nestle Health Science US Holdings, Inc.
3.82M
4.79%
--
--
Apr 25, 2025
BlackRock Institutional Trust Company, N.A.
3.44M
4.31%
+105.31K
+3.16%
Jun 30, 2025
Black Sheep, FLP
2.08M
2.6%
--
--
Apr 25, 2025
Tieton Capital Management, LLC
1.58M
1.98%
-404.73K
-20.38%
Jun 30, 2025
Fried (Robert N)
1.65M
2.06%
+66.67K
+4.22%
Apr 25, 2025
Arrowstreet Capital, Limited Partnership
1.12M
1.4%
+129.51K
+13.08%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.30M
1.62%
+116.27K
+9.86%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
AdvisorShares Insider Advantage ETF
0.98%
Gabelli Love Our Planet & People ETF
0.27%
ALPS Barron's 400 ETF
0.2%
Even Herd Long Short ETF
0.11%
Principal U.S. Small-Cap ETF
0.08%
iShares Micro-Cap ETF
0.08%
Vanguard US Quality Factor ETF
0.07%
Vanguard US Momentum Factor ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
WisdomTree US SmallCap Quality Growth Fund
0.06%
查看更多
AdvisorShares Insider Advantage ETF
占比0.98%
Gabelli Love Our Planet & People ETF
占比0.27%
ALPS Barron's 400 ETF
占比0.2%
Even Herd Long Short ETF
占比0.11%
Principal U.S. Small-Cap ETF
占比0.08%
iShares Micro-Cap ETF
占比0.08%
Vanguard US Quality Factor ETF
占比0.07%
Vanguard US Momentum Factor ETF
占比0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.06%
WisdomTree US SmallCap Quality Growth Fund
占比0.06%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Niagen Bioscience Inc的前五大股东是谁?

Niagen Bioscience Inc 的前五大股东如下:
Brilliant Dynasty Ltd持有股份:11.41M,占总股份比例:14.31%。
Pioneer Step Holdings, Ltd.持有股份:6.92M,占总股份比例:8.67%。
The Vanguard Group, Inc.持有股份:3.92M,占总股份比例:4.92%。
Nestle Health Science US Holdings, Inc.持有股份:3.82M,占总股份比例:4.79%。
BlackRock Institutional Trust Company, N.A.持有股份:3.44M,占总股份比例:4.31%。

Niagen Bioscience Inc的前三大股东类型是什么?

Niagen Bioscience Inc 的前三大股东类型分别是:
Brilliant Dynasty Ltd
Pioneer Step Holdings, Ltd.
The Vanguard Group, Inc.

有多少机构持有Niagen Bioscience Inc(NAGE)的股份?

截至2025Q3,共有277家机构持有Niagen Bioscience Inc的股份,合计持有的股份价值约为29.97M,占公司总股份的37.55%。与2025Q2相比,机构持股有所增加,增幅为-30.28%。

哪个业务部门对Niagen Bioscience Inc的收入贡献最大?

在--,--业务部门对Niagen Bioscience Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI